The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
MET inhibitor resistance in patients with MET exon 14-altered lung cancers.
 
Robin Guo
No Relationships to Disclose
 
Michael Offin
Consulting or Advisory Role - PharmaMar
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck Sharp & Dohme
 
A. Rose Brannon
Employment - Novartis Institutes for BioMedical Research
Stock and Other Ownership Interests - Johnson & Johnson
 
Andrew Chow
No Relationships to Disclose
 
Lukas Delasos
No Relationships to Disclose
 
Romel Somwar
Research Funding - Helsinn Healthcare
Travel, Accommodations, Expenses - Helsinn Healthcare
 
Olivia Wilkins
No Relationships to Disclose
 
Kerry Scott
Employment - NantWorks
 
Yuan Tian
Employment - NantWorks
 
Fabiola Cecchi
Stock and Other Ownership Interests - AstraZeneca/MedImmune; NantHealth
 
Todd A. Hembrough
Employment - NantWorks
Leadership - NantWorks
Stock and Other Ownership Interests - NantHealth; NantWorks
Patents, Royalties, Other Intellectual Property - Patents issued and pending as an employee of NantOmics, LLC
 
Bob T. Li
Consulting or Advisory Role - Biosceptre International; Guardant Health; Hengrui Therapeutics; Mersana; Roche; Thermo Fisher Scientific
Research Funding - AstraZeneca (Inst); BioMed Valley Discoveries (Inst); Daiichi Sankyo (Inst); GRAIL (Inst); Guardant Health (Inst); Hengrui Therapeutics (Inst); Illumina (Inst); Roche/Genentech (Inst)
 
Charles M. Rudin
Consulting or Advisory Role - Abbvie; Ascentage Pharma; AstraZeneca; Bicycle Therapeutics; Bristol-Myers Squibb; Celgene; Daiichi Sankyo; Daiichi Sankyo; Elucida Oncology; Genentech/Roche; Harpoon Therapeutics; Ipsen; Loxo; PharmaMar; PharmaMar; Seagen
Research Funding - Abbvie/Stemcentrx (Inst); Daiichi Sankyo (Inst); Merck (Inst); Viralytics (Inst)
 
Mark G. Kris
Consulting or Advisory Role - AstraZeneca; Pfizer; Regeneron
Travel, Accommodations, Expenses - AstraZeneca
Other Relationship - Memorial Sloan-Kettering Cancer Center
 
Maria E. Arcila
Honoraria - Invivoscribe
Consulting or Advisory Role - AstraZeneca
Travel, Accommodations, Expenses - AstraZeneca; Invivoscribe; Raindance Technologies
 
Natasha Rekhtman
No Relationships to Disclose
 
Paul K. Paik
Honoraria - Abbvie; Celgene; Lilly; Takeda
Consulting or Advisory Role - Abbvie; Bristol-Myers Squibb; Celgene; Lilly
Research Funding - Celgene; EMD Serono
Travel, Accommodations, Expenses - EMD Serono
Other Relationship - Takeda
 
Marc Ladanyi
Honoraria - Merck (I)
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Merck (I); NCCN/AstraZeneca; Takeda
Research Funding - Helsinn Therapeutics; Loxo (Inst)
 
Ahmet Zehir
No Relationships to Disclose
 
Alexander E. Drilon
Honoraria - Foundation Medicine; Medscape; MORE Health; OncLive; Peerview; PeerVoice; Physicans' Education Resource; Research to Practice; Targeted Oncology
Consulting or Advisory Role - AstraZeneca; Bayer; BeiGene; BerGenBio; Blueprint Medicines; Exelixis; Genentech/Roche; Helsinn Therapeutics; Hengrui Therapeutics; Ignyta; Loxo; MORE Health; Pfizer; Takeda/Millennium; TP Therapeutics; Tyra Biosciences; Verastem
Patents, Royalties, Other Intellectual Property - Wolters Kluwer (Royalties for Pocket Oncology)
Other Relationship - GlaxoSmithKline; Merck; Taiho Pharmaceutical; Teva